Archazolid-7-O-β-D-glucopyranoside - Isolation, structural elucidation and solution conformation of a novel V-ATPase inhibitor from the myxobacterium Cystobacter violaceus

European Journal of Organic Chemistry

Volumn , Issue 7, 2007, Pages 1196-1202

  Menche, Dirk ^a   Hassfeld, Jorma ^a   Steinmetz, Heinrich ^a   Huss, Markus ^b   Wieczorek, Helmut ^b   Sasse, Florenz ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b UNIVERSITY OF OSNABRÜCK   (Germany)

Author keywords

Archazolid; Glycosides; Inhibitors; Natural products; Polyketides

Indexed keywords

EID: 34249007040     PISSN: 1434193X     EISSN: 10990690     Source Type: Journal    
DOI: 10.1002/ejoc.200600912     Document Type: Article

References (23)

1. H. Wieczorek, D. Brown, S. Grinstein, J. Ehrenfeld, W. R. Harvey, Bioessays 1999, 21, 637-648;
2. T. Nishi, M. Forgac, Nat. Rev. Mol. Cell Biol. 2002, 3, 94-103.
3. P. H. Schlesinger, H. C. Blair, S. L. Teitelbaum, J. C. Edwards, J. Biol. Chem. 1997, 272, 18636-18643.
4. S. R. Sennoune, D. Luo, R. Martinez-Zaguilan, Cell. Biochem. Biophys. 2004, 40, 185-206.
5. G. Höfle, H. Reichenbach, F. Sasse, H. Steinmetz, German Patent DE 4142951C1, 1993.
6. F. Sasse, H. Steinmetz, G. Höfle, H. Reichenbach, J. Antibiot. 2003, 56, 520-525.
7. For a review on cytotoxic secondary metabolites from myxobacteria, see: H. Reichenbach, G. Höfle, in: Drug Discovery from Nature (Eds.: S. Grabley, R. Thierecke), Springer Verlag, Berlin, 1999, pp. 149-179.
8. M. Huss, F. Sasse, B. Kunze, R. Jansen, H. Steinmetz, G. Ingenhorst, A. Zeeck, H. Wieczorek, BMC Biochemistry 2005, 6, 13; http://www.biomedcentral.com/1471-2091-6-13.
9. [7]. This subunit forms an oligomer, building up a ring structure of six or more copies, which transports protons across the membrane. In addition, Murata et al. recently described the structure of the ring from a bacterial V-ATPase at 2.1 Å resolution and showed that 10 copies form the c ring. These results make a detailed study on the 3D structure of novel inhibitors, such as the one described here, a rewarding task: T. Murata, I. Yamato, Y. Kakinuma, A. G. Leslie, J. E. Walker, Science 2005, 308, 654-659;
10. see also: T. Nishi, M. Forgac, Nat. Rev. Mol. Cell Biol. 2002, 3, 94-103.
11. For illustrative references along these lines, see: S. R. Roffler, S. M. Wang, J. W. Chern, M. Y. Yeh, E. Tung, Biochem. Pharmacol. 1991, 42, 2062-2065;
12. L. F. Tietze, R. Hannemann, W. Buhr, M. Lögers, P. Menningen, M. Lieb, D. Starck, T. Grote, A. Döring, I. Schuberth, Angew. Chem. Int. Ed. Engl. 1996, 35, 2674-2677.
13. J. Hassfeld, C. Farès, H. Steinmetz, T. Carlomagno, D. Menche, Org. Lett. 2006, 8, 4751-4754.
14. No chemical analyses of the secondary metabolites of this myxobacterial species have previously been reported.
15. S. Seo, Y. Tomita, K. Tori, Y. Yoshimura, J. Am. Chem. Soc. 1978, 100, 3331-3339.
16. T. R. Hoye, P. R. Hanson, J. R. Vyvyan, J. Org. Chem. 1994, 59, 4096-4103;
17. T. R. Hoye, H. Zhao, J. Org. Chem. 2002, 67, 4014-4016.
18. F. Mohamadi, N. G. J. Richards, W. C. Guida, R. Liskamp, M. Lipton, C. Caufield, G. Chang, T. Hendrickson, W. C. Still, J. Comput. Chem. 1990, 11, 440-467.
19. W. C. Still, A. Tempczyk, R. C. Hawley, T. Hendrickson, J. Am. Chem. Soc. 1990, 112, 6127-6129.
20. M. F. Chaplin, Anal. Biochem. 1982, 123, 336-341.
21. T. Mosman, J. Immunol. Methods 1983, 65, 55-63.
22. M. Huss, G. Ingenhorst, S. König, M. Gassel, S. Dröse, A. Zeeck, K. Altendorf, H. Wieczorek, J. Biol. Chem. 2002, 277, 40544-40548.
23. H. Wieczorek, M. Cioffi, U. Klein, W. R. Harvey, H. Schweikl, M. G. Wolfersberger, Methods Enzymol. 1990, 192, 608-616.